Evolution of an Administration Technique for Dexamethasone Intraocular Suspension 9% | ASCRS
Video
Evolution of an Administration Technique for Dexamethasone Intraocular Suspension 9%
May 2020
Meeting: 2020 Virtual Annual Meeting
Presenter: Michael Saidel, MD
This content is only available for ASCRS Members

This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

Dexamethasone intraocular suspension 9% is delivered at the end of cataract surgery as a single 5-mcL droplet behind the iris. Early experience has shown that several factors may affect whether the drug is placed successfully and remains in place. This video will illustrate the author’s own learning curve and the development of a reliably successful administration technique.
View more Films

This film was submitted to the 38th Annual ASCRS Film Festival within the 2020 ASCRS Virtual Annual Meeting.. 

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.